𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1287 PROSTAGLANDIN EP4 RECEPTOR KNOCKDOWN SUPPRESSES PROSTATE CANCER GROWTH IN VIVO

✍ Scribed by Huang, Hosea; Murphy, Thomas; Shu, Ping; Lewandoski, Patricia; Pregenzer, Gerard; Carpenter, Christina; Jordan, Mark

Book ID
123385887
Publisher
Lippincott Williams and Wilkins
Year
2011
Tongue
English
Weight
177 KB
Volume
185
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prostaglandin E2 induces vascular endoth
Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway
✍ Xingya Wang; Russell D. Klein πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 295 KB

Prostaglandin E 2 (PGE 2 ) has been shown to induce expression of vascular endothelial growth factor (VEGF) and other signaling molecules in several cancers. PGE 2 elicits its functions though four G-protein coupled membrane receptors (EP1-4). In this study, we investigated the role of EP receptors

Apigenin suppresses insulin-like growth
Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study
✍ Sanjeev Shukla; Sanjay Gupta πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 335 KB

## Abstract Deregulation of insulin‐like growth factor (IGF)‐I/IGF‐IR signaling has been implicated in the development and progression of prostate cancer. Agents that can suppress the mitogenic activity of the IGF/IGF‐IR growth axis may be of preventive or therapeutic value. We have previously demo